SN reduces the expression of VEGF directly by downregulating phospho-ERK1/2(p-ERK1/2)-HIF-1α and indirectly via STAT3 signaling pathways in pancreatic cancer (PCC) cells. This evidence concerns the gene MAPK3 and pancreatic neoplasm.